Manuel Kussmann

424 total citations
30 papers, 308 citations indexed

About

Manuel Kussmann is a scholar working on Infectious Diseases, Pharmacology and Nephrology. According to data from OpenAlex, Manuel Kussmann has authored 30 papers receiving a total of 308 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Infectious Diseases, 10 papers in Pharmacology and 9 papers in Nephrology. Recurrent topics in Manuel Kussmann's work include Antimicrobial Resistance in Staphylococcus (10 papers), Antibiotics Pharmacokinetics and Efficacy (10 papers) and Dialysis and Renal Disease Management (9 papers). Manuel Kussmann is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (10 papers), Antibiotics Pharmacokinetics and Efficacy (10 papers) and Dialysis and Renal Disease Management (9 papers). Manuel Kussmann collaborates with scholars based in Austria, Germany and Bangladesh. Manuel Kussmann's co-authors include Heinz Burgmann, Wolfgang Poeppl, Markus Zeitlinger, Martin Wiesholzer, Gottfried Reznicek, Athanasios Makristathis, Heimo Lagler, Ludwig Traby, Petra Pichler and Michael Ramharter and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Manuel Kussmann

28 papers receiving 304 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Manuel Kussmann Austria 11 125 69 64 57 55 30 308
Hasan Selçuk Özger Türkiye 9 196 1.6× 72 1.0× 29 0.5× 26 0.5× 66 1.2× 47 340
Yohann Dubois France 5 41 0.3× 70 1.0× 17 0.3× 29 0.5× 155 2.8× 7 339
Linda Graviss United States 9 116 0.9× 22 0.3× 31 0.5× 8 0.1× 103 1.9× 14 305
Hari Polenakovik United States 9 110 0.9× 20 0.3× 40 0.6× 7 0.1× 60 1.1× 27 208
Tetsuya Horino Japan 10 104 0.8× 41 0.6× 43 0.7× 6 0.1× 93 1.7× 29 277
K Murono Japan 13 115 0.9× 119 1.7× 55 0.9× 8 0.1× 175 3.2× 43 466
R. Brigg Turner United States 11 167 1.3× 20 0.3× 145 2.3× 11 0.2× 94 1.7× 16 323
Rosy Priya Kodiyanplakkal United States 7 113 0.9× 46 0.7× 27 0.4× 12 0.2× 66 1.2× 15 285
Anubhav Kanwar United States 10 166 1.3× 56 0.8× 8 0.1× 19 0.3× 56 1.0× 24 307
Oriol Gasch Spain 13 293 2.3× 66 1.0× 37 0.6× 6 0.1× 180 3.3× 39 446

Countries citing papers authored by Manuel Kussmann

Since Specialization
Citations

This map shows the geographic impact of Manuel Kussmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manuel Kussmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manuel Kussmann more than expected).

Fields of papers citing papers by Manuel Kussmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manuel Kussmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manuel Kussmann. The network helps show where Manuel Kussmann may publish in the future.

Co-authorship network of co-authors of Manuel Kussmann

This figure shows the co-authorship network connecting the top 25 collaborators of Manuel Kussmann. A scholar is included among the top collaborators of Manuel Kussmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manuel Kussmann. Manuel Kussmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zeitlinger, Markus, et al.. (2025). Synergistic activity of fosfomycin and flucloxacillin against methicillin-susceptible and methicillin-resistant Staphylococcus aureus: in vitro and in vivo assessment. Medical Microbiology and Immunology. 214(1). 32–32. 1 indexed citations
2.
3.
Kussmann, Manuel, Sylvia Metz‐Schimmerl, Selma Tobudic, et al.. (2024). Successful treatment of glandular tularemia with azithromycin in a pregnant woman in Austria. Infection. 52(3). 1181–1184. 2 indexed citations
4.
Traby, Ludwig, et al.. (2024). Staphylococcus aureus small colony variants: A potentially underestimated microbiological challenge in peritoneal dialysis. International Journal of Antimicrobial Agents. 63(5). 107135–107135. 2 indexed citations
5.
Fuhr, Uwe, Martin Wiesholzer, Manuel Kussmann, et al.. (2023). Population pharmacokinetics of meropenem in patients undergoing automated peritoneal dialysis. Peritoneal Dialysis International. 43(5). 402–410.
6.
7.
Jorda, Anselm, Manuel Kussmann, Jolanta M. Siller‐Matula, et al.. (2022). Convalescent Plasma Treatment in Patients with Covid-19: A Systematic Review and Meta-Analysis. Frontiers in Immunology. 13. 817829–817829. 28 indexed citations
8.
Kussmann, Manuel, et al.. (2021). Synergistic Effect of Cefazolin Plus Fosfomycin Against Staphylococcus aureus in vitro and in vivo in an Experimental Galleria mellonella Model. Frontiers in Pharmacology. 12. 685807–685807. 10 indexed citations
9.
Kussmann, Manuel, et al.. (2021). Treatment of legionellosis including a single intravenous dose of 1.5 g azithromycin: 18-year experience at a tertiary care hospital. International Journal of Antimicrobial Agents. 59(1). 106481–106481. 4 indexed citations
10.
Kovarík, J, Anna Nele Herdina, Christopher C. Kaltenecker, et al.. (2021). Identification of Immune Activation Markers in the Early Onset of COVID-19 Infection. Frontiers in Cellular and Infection Microbiology. 11. 651484–651484. 8 indexed citations
11.
Tobudic, Selma, Manuel Kussmann, Markus Zeitlinger, et al.. (2020). Compatibility of aztreonam in four commercial peritoneal dialysis fluids. Scientific Reports. 10(1). 1788–1788. 3 indexed citations
12.
Kussmann, Manuel, et al.. (2020). Different Types of Coagulase Are Associated With 28-Day Mortality in Patients With Staphylococcus aureus Bloodstream Infections. Frontiers in Cellular and Infection Microbiology. 10. 236–236. 4 indexed citations
13.
Kussmann, Manuel, Petra Pichler, Markus Zeitlinger, et al.. (2019). Compatibility of ciprofloxacin with commercial peritoneal dialysis solutions. Scientific Reports. 9(1). 6512–6512. 11 indexed citations
14.
Kussmann, Manuel, et al.. (2018). Dalbavancin for treatment of implant-related methicillin-resistant Staphylococcus aureus osteomyelitis in an experimental rat model. Scientific Reports. 8(1). 9661–9661. 15 indexed citations
15.
Matzneller, Peter, Manuel Kussmann, Alexandra Maier‐Salamon, et al.. (2018). Pharmacokinetics of the P-gp Inhibitor Tariquidar in Rats After Intravenous, Oral, and Intraperitoneal Administration. European Journal of Drug Metabolism and Pharmacokinetics. 43(5). 599–606. 24 indexed citations
16.
Makristathis, Athanasios, Nicole Harrison, Franz Ratzinger, et al.. (2018). Substantial diagnostic impact of blood culture independent molecular methods in bloodstream infections: Superior performance of PCR/ESI-MS. Scientific Reports. 8(1). 16024–16024. 11 indexed citations
17.
Poeppl, Wolfgang, Manuel Kussmann, Petra Pichler, et al.. (2018). Compatibility of linezolid with commercial peritoneal dialysis solutions. American Journal of Health-System Pharmacy. 75(19). 1467–1477. 3 indexed citations
18.
Kussmann, Manuel, Anja Baumann, Markus Zeitlinger, et al.. (2017). Compatibility of fosfomycin with different commercial peritoneal dialysis solutions. European Journal of Clinical Microbiology & Infectious Diseases. 36(11). 2237–2242. 11 indexed citations
19.
Lagler, Heimo, Nicole Harrison, Manuel Kussmann, et al.. (2017). Direct detection of Anaplasma phagocytophilum by polymerase chain reaction followed by electrospray ionization mass spectrometry from human blood. International Journal of Infectious Diseases. 60. 61–63. 6 indexed citations
20.
Kussmann, Manuel, Linda C. Schuster, Markus Zeitlinger, et al.. (2015). The influence of different peritoneal dialysis fluids on the in vitro activity of ampicillin, daptomycin, and linezolid against Enterococcus faecalis. European Journal of Clinical Microbiology & Infectious Diseases. 34(11). 2257–2263. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hasan Selçuk Özger Breakdown of academic impact, for papers by Yohann Dubois Breakdown of academic impact, for papers by Linda Graviss Breakdown of academic impact, for papers by Hari Polenakovik Breakdown of academic impact, for papers by Tetsuya Horino Breakdown of academic impact, for papers by K Murono Breakdown of academic impact, for papers by R. Brigg Turner Breakdown of academic impact, for papers by Rosy Priya Kodiyanplakkal Breakdown of academic impact, for papers by Anubhav Kanwar Breakdown of academic impact, for papers by Oriol Gasch
Rankless by CCL
2026